{"id":"NCT01312922","sponsor":"PharmaNeuroBoost N.V.","briefTitle":"Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)","officialTitle":"Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2012-11","completion":"2012-12","firstPosted":"2011-03-11","resultsPosted":"2022-04-07","lastUpdate":"2022-04-07"},"enrollment":555,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"PNB01 fixed dose combination of pipamperone and citalopram","otherNames":[]},{"type":"DRUG","name":"Citalopram","otherNames":[]},{"type":"DRUG","name":"Pipamperone","otherNames":[]}],"arms":[{"label":"PNB01","type":"EXPERIMENTAL"},{"label":"citalopram","type":"ACTIVE_COMPARATOR"},{"label":"pipamperone","type":"SHAM_COMPARATOR"}],"summary":"The overall objective of this trial is to demonstrate clinically relevant superior antidepressant efficacy of the fixed dose combination PNB01 (low dose pipamperone and citalopram) over reference antidepressant treatment with citalopram alone, and a low dose of psychoactive pipamperone alone in patients with moderate to severe Major Depressive Disorder.\n\nThis study was specifically designed to assess patient related outcome (PRO) parameters using an Interactive Voice Response System (IVRS) via telephone.","primaryOutcome":{"measure":"Early and Sustained (Antidepressant) Response (ESR) Rate","timeFrame":"From (end of) Week 2 visit to (end of) Week 6 visit","effectByArm":[{"arm":"PNB01","deltaMin":17,"sd":null},{"arm":"Citalopram","deltaMin":17,"sd":null},{"arm":"Pipamperone","deltaMin":17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"1.000"},{"comp":"OG000 vs OG002","p":"1.000"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":185},"commonTop":["Somnolence","Headache","Nausea","Dry Mouth","Insomnia"]}}